Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

U.S. District Judge Jon Tigar said Monday that the federal government cannot force recipients to halt programs that promote ...

The U.S. is up to 1,168 confirmed measles cases this year. Texas added four cases in the last week, which shows continued ...

The Advisory Committee for Immunization practices helps the agency make recommendations on who should get certain vaccines.

HHS Secretary Robert F. Kennedy on Monday removed all 17 members of the expert panel that makes vaccine policy ...

Milwaukee County Executive Davis Crowley held a news conference on Monday, June 9 to stress the importance of recreational ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

The U.S. Food and Drug Administration has approved Merck's Enflonsia, a treatment to prevent respiratory syncytial virus lower respiratory tract disease in newborns and infants. The company said ...

While Lyme disease gets the most attention – and affects the most people – there are other tick-borne bacteria and diseases ...

The average woman's weight can vary depending on age, physical traits, certain health conditions, metabolism, appetite, and ...